Supplementary Figure 2 from Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
Koichi Nishijo(Kyoto University), Charles Keller(Children's Cancer Therapy Development Institute), Joel Michalek(The University of Texas at San Antonio Health Science Center), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Frederic G. Barr(National Institutes of Health), Min Jung Cho, Gary B. Chisholm(Buck Institute for Research on Aging), Chiayeng Wang(University of Illinois Chicago), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), R. Lor Randall(University of California Davis Medical Center), Bruce J. Aronow(Cincinnati Children's Hospital Medical Center), Stephen J. Qualman(Nationwide Children's Hospital), Amanda T. McCleish(The University of Texas at San Antonio Health Science Center), Lei Zhang(Shandong University of Traditional Chinese Medicine), Qingrong Chen(National Cancer Institute), A. Y. Rodriguez, Robin D. LeGallo(Nationwide Children's Hospital), Brian P. Rubin(Cleveland Clinic), Suresh I. Prajapati(The University of Texas at San Antonio Health Science Center), Javed Khan(Kent State University)
Cited by 0
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871